New ISB research uses Truveta Data to study treatment for hospitalized pregnant patients with COVID-19

Scientists from the Hadlock and Hood-Price Lab at ISB have published new research in the JMIR Public Health and Surveillance journal. The work explores the National Institute of Health (NIH) recommendation for prophylactic anticoagulant use for pregnant patients hospitalized for the manifestation of COVID-19.

New ISB research uses Truveta Data to study treatment for hospitalized pregnant patients with COVID-19
New ISB research uses Truveta Data to study treatment for hospitalized pregnant patients with COVID-19